The PEAD projected a Neutral outlook for $GSK after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 77.78%.
Professional grade tools including Earning momentum and Post earning announcement drift price forecast. www.epsmomentum.com